Novel truncating germline variant reinforces TINF2 as a susceptibility gene for familial non-medullary thyroid cancer

被引:0
|
作者
Oriola, Josep [1 ,2 ]
Diez, Orland [3 ]
Mora, Mireia [4 ,5 ]
Halperin, Irene [6 ]
Martinez, Sandra [7 ]
Masas, Miriam [8 ]
Tenes, Anna [8 ]
Bernal, Anna [9 ]
Duran, Rafael [10 ]
Orois, Aida [11 ]
机构
[1] Hosp Clin Barcelona, Biochem & Mol Genet Dept, Barcelona 08036, Spain
[2] Univ Barcelona, Fac Med & Ciencies Salut, Biomed, Barcelona, Spain
[3] Vall Hebron Inst dOncol, Area Clin & Mol Genet, Canc Genet Grp, Barcelona, Spain
[4] Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Endocrinol & Nutr Dept, Barcelona, Spain
[5] Univ Barcelona, Fac Med & Ciencies Salut, Barcelona, Spain
[6] Hosp Clin Barcelona, Endocrinol Dept, ICMDM, Barcelona, Spain
[7] Hosp Gen Elda, FED Endocrinol & Nutr, Elda, Spain
[8] Vall dHebron Univ Hosp, Clin & Mol Genet Area, Barcelona, Spain
[9] Hosp Clin Barcelona, Biochem & Mol Genet, Barcelona, Spain
[10] Hosp Gen Elda, Serv Patol, Elda, Spain
[11] Hosp Clin Barcelona, Endocrinol, ICMDM, Barcelona, Spain
关键词
Endocrine Gland Neoplasms; Frameshift Mutation; Genetics; Medical; Genetic Testing; Germ-Line Mutation; DYSKERATOSIS-CONGENITA; MUTATION;
D O I
10.1136/jmg-2024-110185
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background It has long been observed that there are families in which non-medullary thyroid cancer (NMTC) occurs, but few syndromes and genes have been described to date. Proteins in the shelterin complex have been implied in cancer. Here, we have studied shelterin genes in families affected by NMTC (FNMTC). Methods We performed whole-exome sequencing (WES) in 10 affected individuals from four families with at least three affected members. Polymerase chain reaction (PCR) and Sanger sequencing were performed to search for variants in the TINF2 gene in 40 FNMTC families. TINF2 transcripts and loss of heterozygosity (LOH) were studied in several affected patients of one family. Results We found the c.507G>T variant in heterozygosis in the TINF2 gene in one family, co-segregating in all five affected members. This variant affects the normal splicing. LOH was not observed. Conclusions Our results reinforce the TINF2 gene as a susceptibility cause of FNMTC suggesting the importance of location of frameshift variants in TINF2. According to our data and previous literature, TINF2 pathogenic variants appear to be a significant risk factor for the development of NMTC and/or melanoma.
引用
收藏
页码:939 / 942
页数:4
相关论文
共 22 条
  • [1] A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres
    He, Huiling
    Li, Wei
    Comiskey, Daniel F.
    Liyanarachchi, Sandya
    Nieminen, Taina T.
    Wang, Yanqiang
    DeLap, Katherine E.
    Brock, Pamela
    de la Chapelle, Albert
    THYROID, 2020, 30 (02) : 204 - 213
  • [2] Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer
    Alzahrani, Ali S.
    Alswailem, Meshael
    Alghamdi, Balgees
    Al-Hindi, Hindi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09) : 2539 - 2544
  • [3] Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility
    Susanna Koivuluoma
    Sandra Vorimo
    Tiina M. Mattila
    Anna Tervasmäki
    Timo Kumpula
    Outi Kuismin
    Robert Winqvist
    Jukka Moilanen
    Tuomo Mantere
    Katri Pylkäs
    Familial Cancer, 2023, 22 : 13 - 17
  • [4] Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility
    Koivuluoma, Susanna
    Vorimo, Sandra
    Mattila, Tiina M.
    Tervasmaki, Anna
    Kumpula, Timo
    Kuismin, Outi
    Winqvist, Robert
    Moilanen, Jukka
    Mantere, Tuomo
    Pylkas, Katri
    FAMILIAL CANCER, 2023, 22 (01) : 13 - 17
  • [5] Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
    Miasaki, Fabiola Yukiko
    Fuziwara, Cesar Seigi
    Carvalho, Gisah Amaral de
    Kimura, Edna Teruko
    GENES, 2020, 11 (11) : 1 - 21
  • [6] Genetic susceptibility to hereditary non-medullary thyroid cancer
    Kamani, Tina
    Charkhchi, Parsa
    Zahedi, Afshan
    Akbari, Mohammad R.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [7] Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum
    Zhou, Jingan
    Singh, Preeti
    Yin, Kanhua
    Wang, Jin
    Bao, Yujia
    Wu, Menghua
    Pathak, Kush
    McKinley, Sophia K.
    Braun, Danielle
    Lubitz, Carrie C.
    Hughes, Kevin S.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6590 - 6600
  • [8] Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing
    Barbalho de Mello, Luis Eduardo
    Ribeiro Carneiro, Thaise Nayane
    Araujo, Aline Neves
    Alves, Camila Xavier
    Favoretto Galante, Pedro Alexandre
    Buzatto, Vanessa Candiotti
    de Almeida, Maria das Gracas
    Vermeulen-Serpa, Karina Marques
    de Lima Vale, Sancha Helena
    de Pinto Paiva, Fernando Jose
    Brandao-Neto, Jose
    Cerutti, Janete Maria
    ENDOCRINE CONNECTIONS, 2022, 11 (01)
  • [9] Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys
    Sanchez-Ares, Maria
    Cameselle-Garcia, Soledad
    Abdulkader-Nallib, Ihab
    Rodriguez-Carnero, Gemma
    Beiras-Sarasquete, Carolina
    Punal-Rodriguez, Jose Antonio
    Cameselle-Teijeiro, Jose Manuel
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma
    Jiang, Yu-Jia
    Xia, Yun
    Hu, Yi-Xuan
    Han, Zhuo-Jun
    Guo, An-Yuan
    Huang, Tao
    THYROID, 2024, 34 (05) : 583 - 597